Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Hormonal side effects in women: typical versus atypical antipsychotic treatment.

Dickson RA, Seeman MV, Corenblum B.

J Clin Psychiatry. 2000;61 Suppl 3:10-5. Review.

2.

[Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].

Konarzewska B, Szulc A, Popławska R, Galińska B, Juchnowicz D.

Psychiatr Pol. 2008 Jan-Feb;42(1):87-95. Review. Polish.

PMID:
18567406
3.

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.

O'Keane V.

J Psychopharmacol. 2008 Mar;22(2 Suppl):70-5. doi: 10.1177/0269881107088439. Review.

PMID:
18477623
4.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Haddad PM, Wieck A.

Drugs. 2004;64(20):2291-314. Review.

PMID:
15456328
5.

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.

Halbreich U, Kinon BJ, Gilmore JA, Kahn LS.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:53-67. Review.

PMID:
12504072
6.

Antipsychotic-induced hyperprolactinemia and sexual dysfunction.

Compton MT, Miller AH.

Psychopharmacol Bull. 2002 Winter;36(1):143-64. Review.

PMID:
12397853
7.

[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C.

Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Review. French.

PMID:
23928066
8.

[The relationship between antipsychotic-induced hyperprolactinemia and menstrual disorders in women with schizophrenia; a systematic review].

Ouwehand AJ, Mollema-Schelwald BM, Knegtering H.

Tijdschr Psychiatr. 2012;54(10):861-8. Review. Dutch.

9.

Prolactin awareness: an essential consideration for physical health in schizophrenia.

Montejo AL.

Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14. doi: 10.1016/j.euroneuro.2008.02.004. Review.

PMID:
18346598
11.

What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?

Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:109-23. Review.

PMID:
12650685
12.

[Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].

Riecher-Rössler A, Schmid C, Bleuer S, Birkhäuser M.

Neuropsychiatr. 2009;23(2):71-83. German.

PMID:
19573500
13.

Sexual dysfunction in schizophrenia: focus on recent evidence.

Baggaley M.

Hum Psychopharmacol. 2008 Apr;23(3):201-9. doi: 10.1002/hup.924. Review.

PMID:
18338766
14.

The effects of atypical antipsychotics on serum prolactin levels.

Hamner M.

Ann Clin Psychiatry. 2002 Sep;14(3):163-73. Review.

PMID:
12585566
15.

Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice.

Smith S.

J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S27-32. Review.

PMID:
12832947
16.

Antipsychotic-induced hyperprolactinemia.

Bostwick JR, Guthrie SK, Ellingrod VL.

Pharmacotherapy. 2009 Jan;29(1):64-73. doi: 10.1592/phco.29.1.64. Review.

17.

Some adverse effects of antipsychotics: prevention and treatment.

Lader M.

J Clin Psychiatry. 1999;60 Suppl 12:18-21. Review.

18.

Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.

Nunes LV, Moreira HC, Razzouk D, Nunes SO, Mari Jde J.

J Sex Marital Ther. 2012;38(3):281-301. doi: 10.1080/0092623X.2011.606883. Review.

PMID:
22533871
19.

Long-term considerations after switching antipsychotics.

Weiden PJ, Aquila R, Emanuel M, Zygmunt A.

J Clin Psychiatry. 1998;59 Suppl 19:36-49. Review.

20.

Hyperprolactinaemia and antipsychotic therapy in schizophrenia.

Hummer M, Huber J.

Curr Med Res Opin. 2004;20(2):189-97. Review.

PMID:
15006013

Supplemental Content

Support Center